Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended December 31, ...
A therapeutic plasma exchange (TPE) recently saved the life of a puppy that overdosed on a non-steroidal anti-inflammatory drug (NSAID). The 6-month-old patient, Indy, had ingested a high dose ...
Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve ...
Meg Flippin, Benzinga Staff Writer CHICAGO, IL AND FORT WORTH, TX / ACCESS Newswire / March 24, 2026 /Actuate Therapeutics, Inc. (NASDAQ:ACTU) is a clinical-stage biopharmaceutical company advancing ...
NRx Pharmaceuticals (NASDAQ:NRXP) executives used the company’s fourth-quarter 2025 results call to outline what they described as a “pivotal and transformative” year, highlighting advancing ...
Background The COVID-19 pandemic exposed critical care disparities in low-resource settings. In Ethiopia, intensive care unit (ICU) expansion had begun prior to COVID-19 but accelerated during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results